Related Experiment Video
Updated: Sep 13, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
A chlorinated diketopiperazine antibiotic targets Mycobacterium tuberculosis
Libang Liang1, Jeffrey Quigley1, Monique Theriault1
1Department of Biology, Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts, USA.
None:
We describe a novel macrocyclic peptide, speirobactin, produced by Photorhabdus temperata that selectively kills Mycobacterium tuberculosis. A nonribosomal peptide synthase containing two linear modules codes for the synthesis of speirobactin. The biosynthetic operon contains a pentapeptide-repeat protein as a resistance gene. Genomic analysis of speirobactin-resistant mutants of M. tuberculosis led to the identification of DNA gyrase as the molecular target. The mutations were recreated and show that DNA gyrase is the only target. Transcriptome analysis of M. tuberculosis treated with antibiotics shows that speirobactin clusters close to fluoroquinolones, supporting its action against the DNA gyrase.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

